Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).

Source:http://linkedlifedata.com/resource/pubmed/id/19427428

Am. J. Cardiol. 2009 May 15 103 10 1359-63

Download in:

View as

General Info

PMID
19427428